Back to Trades
Legorreta Pablo G.
CEOChairman of the BoardDirectorCIK 0001507678
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Across 6 filings between 2025–2026, Legorreta Pablo G., CEO, Chairman of the Board, Director, has disclosed $244.3K in transactions — spread across 2 companies. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Nov 6 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| Aug 7 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| May 29 | PROK PROKIDNEY CORP. | Legorreta Pablo G. | Insider | Award | $244.3K |
| May 8 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| Nov 7 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| Aug 8 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
6 filings